Immunohistochemical staining was positive for CD1a, S‐100, CD68, and CD163, and genetic testing confirmed the presence of a BRAF p.V600E mutation, supporting the diagnosis of GIT‐LCH (Figure 4). The gene discussed is BRAF; the disease is Langerhans cell histiocytosis.